Sangamo Therapeutics (SGMO) Stock Price, Quote, News & History

Q: What sector and industry does Sangamo Therapeutics (SGMO) operate in?

Sangamo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Sangamo Therapeutics (SGMO) Stock Price, Quote, News & History

SGMONASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$0.5679

0.03246.05%

At close: Feb 2, 4:00 PM EST

$0.5645

-0.0034-0.60%

After Hours: 7:48 PM EST

Overview

News Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$0.52

Close

$0.57

Volume / Avg.

7.17M / 6.51M

Day Range

$0.49 - $0.60

52 Wk Range

0.36 - 1.40

Market Cap

$189.95M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

70

Short Interest

6.34%

Days to Cover

5.12

Recent Sangamo Therapeutics Inc News

This CarMax Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Avi Kapoor

US Stocks Likely To Open Lower After A Strong Rally: 'Lows Are Likely In And Better Times Are Coming,' Says Expert

U.S. stock futures fell on Tuesday after a stellar rally on Monday. Futures of major benchmark indices were trading lower in premarket.

Rishabh Mishra

Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-76.16M

Investing Cash Flow (TTM)

1.24M

Financing Cash Flow (TTM)

62.94M

Free Cash Flow (TTM)

-76.40M

Capital Expenditure (TTM)

-240.00K

Net Change in Cash (TTM)

-11.98M

Analyst Trends and Forecast

1

Sep 25

1

Nov 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$176.00M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

4.04

PB Ratio (TTM)

28.86

Earnings Yield % (TTM)

-84.03%

Earnings Yield % (FWD)

-20.54%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.02

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$29.62M

Debt to Equity

4.07

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$0.52

Close

$0.57

Volume / Avg.

7.17M / 6.51M

Day Range

$0.49 - $0.60

52 Wk Range

0.36 - 1.40

Market Cap

$189.95M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

70

Short Interest

6.34%

Days to Cover

5.12

About

Sector

Health Care

Industry

Biotechnology

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the P...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Sangamo Therapeutics (SGMO) stock?

A

You can purchase shares of Sangamo Therapeutics (NASDAQ:SGMO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Sangamo Therapeutics (SGMO) competitors?

A

Other companies in Sangamo Therapeutics’s space includes: Kalaris Therapeutics Inc (NASDAQ:KLRS), Innate Pharma SA (NASDAQ:IPHA), Tharimmune Inc (NASDAQ:THAR), Galectin Therapeutics Inc (NASDAQ:GALT) and Humacyte Inc (NASDAQ:HUMA).

Q

What is the forecast, or price target, for Sangamo Therapeutics (SGMO) stock?

A

Sangamo Therapeutics has a consensus price target of $4.85.

Q

What is the current price for Sangamo Therapeutics (SGMO)?

A

The stock price for Sangamo Therapeutics (NASDAQ: SGMO) is $0.5645 last updated February 2, 2026 at 7:48 PM EST.

Q

Does Sangamo Therapeutics (SGMO) pay a dividend?

A

There are no upcoming dividends for Sangamo Therapeutics.

Q

When is Sangamo Therapeutics (NASDAQ:SGMO) reporting earnings?

A

Sangamo Therapeutics does not have any upcoming earnings scheduled.

Q

Is Sangamo Therapeutics (SGMO) going to split?

A

There is no upcoming split for Sangamo Therapeutics.

Q

What sector and industry does Sangamo Therapeutics (SGMO) operate in?

A

Sangamo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Kalaris Therapeutics Inc

Galectin Therapeutics Inc

Zentalis Pharmaceuticals Inc

NASDAQ:ZNTL

$2.40

-4.38%

ProQR Therapeutics NV

NASDAQ:PRQR

$1.60

3.23%

Eledon Pharmaceuticals Inc

NASDAQ:ELDN

$2.28

%

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$0.52

Close

$0.57

Volume / Avg.

7.17M / 6.51M

Day Range

$0.49 - $0.60

52 Wk Range

0.36 - 1.40

Market Cap

$189.95M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

70

Short Interest

6.34%

Days to Cover

5.12

Recent Sangamo Therapeutics Inc News

This CarMax Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Avi Kapoor

US Stocks Likely To Open Lower After A Strong Rally: 'Lows Are Likely In And Better Times Are Coming,' Says Expert

U.S. stock futures fell on Tuesday after a stellar rally on Monday. Futures of major benchmark indices were trading lower in premarket.

Rishabh Mishra

Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-76.16M

Investing Cash Flow (TTM)

1.24M

Financing Cash Flow (TTM)

62.94M

Free Cash Flow (TTM)

-76.40M

Capital Expenditure (TTM)

-240.00K

Net Change in Cash (TTM)

-11.98M

Analyst Trends and Forecast

1

Sep 25

1

Nov 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$176.00M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

4.04

PB Ratio (TTM)

28.86

Earnings Yield % (TTM)

-84.03%

Earnings Yield % (FWD)

-20.54%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.02

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$29.62M

Debt to Equity

4.07

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$0.52

Close

$0.57

Volume / Avg.

7.17M / 6.51M

Day Range

$0.49 - $0.60

52 Wk Range

0.36 - 1.40

Market Cap

$189.95M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

70

Short Interest

6.34%

Days to Cover

5.12

About

Sector

Health Care

Industry

Biotechnology

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the P...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry